ATRC

NEUTRALAnalyst

AtriCure, Inc.

2026-09-30

Price

$56.20

-3.19%

This is the 2026-09-30 snapshot — the signals and analysis for ATRC as of this single trading day.

View full ATRC research hub →

Score2.8Noise

Signals2/8 DNA1/13 Act · 0/4 Risk

SentimentNEUTRALScore: 7

Volume0.7xvs 20d avg

Analysis

Why is ATRC pulling back today? The 3.19% drop on light volume (0.7x average) is a textbook example of healthy consolidation following a massive 15.3% relative outperformance versus the SPY over the last month. Recent analyst upgrades, fueled by the new STS Quality Metric tailwind for the company's EnCompass Clamp, provide a robust fundamental catalyst. Supported by a RISK_ON (EARNINGS) macro regime that aggressively rewards fundamental execution, the PERFECT_STACK and GOLDEN_CROSS technical signals indicate this dip is being actively absorbed by institutions for further high-conviction price discovery.

Fired Signals

GOLDEN CROSSPERFECT STACKBARGAIN HUNTER

Key Takeaways

Actionable Thesis: Treat the current light-volume pullback as a tactical accumulation window, as the structural growth narrative tied to the new STS Quality Metric remains completely intact.
Key Risk: Intensifying competitive threats in the minimally invasive cardiac surgery space and recent insider selling (CTO) could temporarily cap upside momentum.
What to Watch: Ensure price maintains the $51.52 line-in-the-sand to preserve the bullish technical structure, while monitoring Q3 earnings for EnCompass Clamp adoption rates.

← Back to 2026-09-30 View Full ATRC History →Yahoo Finance &nearr;